Patane v. Nestlé Waters N. Am., Inc.
369 F. Supp. 3d 382
D. Conn.2019Background
- Plaintiffs filed a putative class action alleging Poland Spring water is fraudulently marketed as "100% Natural Spring Water" though it does not meet legal definitions of "spring water;" claims are brought under statutory consumer-protection laws and common law fraud and breach of contract for consumers in nine states.
- The first complaint was dismissed for FDCA preemption; plaintiffs amended to plead specific state statutes that (they say) incorporate or mirror the federal FDA "spring water" identity standard.
- Nestlé moved to dismiss raising multiple defenses: Burford abstention, primary jurisdiction, federal preemption, a regulatory "safe harbor," and challenges to the common-law claims (including a later-raised UCC argument).
- The FDA defines "spring water" in 21 C.F.R. § 165.110(a)(2)(vi); many state statutes and regulations either adopt or closely track that federal definition.
- Court limited resolution at pleading stage: factual defenses (safe harbor, validity of state regulatory approvals, UCC-based acceptance defense) require discovery; preemption adjudicated as a matter of law where appropriate.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Burford abstention | Federal forum is proper; plaintiffs seek damages and some injunctive relief but not interference with state administration | Abstain because state regulatory scheme (bottled water regulation) is specialized and ongoing state administration should govern | Declined to abstain — not an extraordinary Burford case and primary relief sought is money damages |
| Primary jurisdiction | Court can adjudicate; FDA has not signaled willingness to make case-specific determinations | Defer to FDA expertise to decide whether Poland Spring meets the federal identity standard | Declined to stay/dismiss — FDA has not shown it will resolve this case-specific issue and federal standard is settled |
| Federal preemption (express/implied/conflict) | State statutes cited by plaintiffs adopt or mirror FDA standard, creating independent state-law bases for claims | Claims are preempted because they seek to enforce federal standards or allegedly exceed the federal/ hydrogeologic standard; conflict preemption argued | Denied as to eight states (CT, ME, MA, NH, NJ, NY, PA, RI): state standards are substantively equivalent to federal standard and not preempted; granted as to Vermont claims (impliedly preempted) |
| Regulatory "safe harbor" and pleading-stage factual defenses | Plaintiffs say prior regulatory approvals do not resolve liability and factual record is disputed | Nestlé says state regulator approvals authorize use of "spring water" label and preclude private suits under state statutes | Denied at pleading stage — safe-harbor and approval-based defenses are fact-bound; may be renewed after discovery |
Key Cases Cited
- Burford v. Sun Oil Co., 319 U.S. 315 (Burford abstention applies only in extraordinary circumstances)
- Quackenbush v. Allstate Ins. Co., 517 U.S. 706 (Burford requires exceptional state interests and risk of disruption)
- Ashcroft v. Iqbal, 556 U.S. 662 (pleading standard: plausibility required)
- Bates v. Dow Agrosciences LLC, 544 U.S. 431 (equivalence concept in preemption analysis at pleading stage)
- Marentette v. Abbott Labs., Inc., 886 F.3d 112 (conflict preemption framework)
- Turek v. Gen. Mills, Inc., 662 F.3d 423 (states may enforce identical FDA requirements under state law)